Management of Acute Gout

First-Line Treatment

The American College of Physicians recommends initiating treatment with corticosteroids, NSAIDs, or colchicine within 24 hours of symptom onset, with corticosteroids considered first-line due to superior safety profile and lower cost 1, 2
The American College of Rheumatology suggests that prednisolone 30-35 mg daily for 3-5 days is the recommended regimen for corticosteroids 1, 2
Corticosteroids are preferred in patients with renal disease, heart failure, cirrhosis, or cardiovascular disease due to their safer profile compared to NSAIDs 1, 2, 3

The European League Against Rheumatism recommends that no single NSAID is superior, and any NSAID at full anti-inflammatory dose is effective, with naproxen, indomethacin, and sulindac being FDA-approved options 1, 4
Colchicine is most effective when started within 12-36 hours of symptom onset, with a dosing regimen of 1.2 mg at first sign of flare, followed by 0.6 mg one hour later (maximum 1.8 mg over one hour) 2, 4

For mild to moderate pain (≤6/10 on pain scale) with 1-3 small joints or 1-2 large joints, monotherapy with any first-line agent is appropriate 4, 3
For severe pain (≥7/10) or polyarticular involvement (≥4 joints), combination therapy is recommended, with effective combinations including colchicine + NSAIDs, oral corticosteroids + colchicine, or intra-articular steroids with any other modality 4, 5

In patients with renal impairment, corticosteroids are the safest option, while NSAIDs are contraindicated in any degree of renal disease 1, 3
In elderly patients, corticosteroids are preferred due to lower risk of serious adverse effects compared to NSAIDs 3

Treatment must be initiated within 24 hours of symptom onset for optimal efficacy, and patients should be educated on the "pill in the pocket" approach to self-initiate treatment at first warning symptoms 4, 2, 3
Urate-lowering therapy should not be stopped during an acute attack, and new urate-lowering therapy should not be initiated during an acute attack 4, 6, 1

Low-dose colchicine 0.5-1 mg daily is first-line prophylaxis when starting any urate-lowering therapy, with low-dose NSAIDs being an alternative if colchicine is not tolerated or contraindicated 6, 2, 3
Prophylaxis should be continued for at least 6 months, or 3 months after achieving target serum urate if no tophi are present 3

Indomethacin should not be used preferentially due to its lack of efficacy advantage over other NSAIDs and potential for more adverse effects 1, 4
High-dose colchicine regimens should not be used as they increase toxicity without improving efficacy 2, 3
Treatment should not be delayed waiting for definitive diagnosis, as early treatment within 24 hours is more important than diagnostic confirmation 4, 2